- Home
- RNG vs AMPH Comparison
RNG vs AMPH Comparison
Compare RNG & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNG
- AMPH
- Stock Information
- Founded
- RNG 1999
- AMPH 1996
- Country
- RNG United States
- AMPH United States
- Employees
- RNG N/A
- AMPH N/A
- Industry
- RNG EDP Services
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- RNG Technology
- AMPH Health Care
- Exchange
- RNG Nasdaq
- AMPH Nasdaq
- Market Cap
- RNG 3.1B
- AMPH 2.5B
- IPO Year
- RNG 2013
- AMPH 2014
- Fundamental
- Price
- RNG $36.21
- AMPH $45.14
- Analyst Decision
- RNG Buy
- AMPH Buy
- Analyst Count
- RNG 15
- AMPH 4
- Target Price
- RNG $40.73
- AMPH $63.00
- AVG Volume (30 Days)
- RNG 1.3M
- AMPH 404.9K
- Earning Date
- RNG 11-07-2024
- AMPH 11-06-2024
- Dividend Yield
- RNG N/A
- AMPH N/A
- EPS Growth
- RNG N/A
- AMPH 17.38
- EPS
- RNG N/A
- AMPH 3.01
- Revenue
- RNG $2,357,154,000.00
- AMPH $723,549,000.00
- Revenue This Year
- RNG $9.88
- AMPH $17.23
- Revenue Next Year
- RNG $7.77
- AMPH $10.25
- P/E Ratio
- RNG N/A
- AMPH $14.78
- Revenue Growth
- RNG 9.33
- AMPH 20.33
- 52 Week Low
- RNG $26.98
- AMPH $36.56
- 52 Week High
- RNG $40.98
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- RNG 48.23
- AMPH 41.78
- Support Level
- RNG $34.13
- AMPH $43.09
- Resistance Level
- RNG $36.04
- AMPH $49.53
- Average True Range (ATR)
- RNG 1.60
- AMPH 1.70
- MACD
- RNG -0.40
- AMPH -0.46
- Stochastic Oscillator
- RNG 10.66
- AMPH 19.50
About RNG RingCentral Inc.
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.